Peptidyl-prolyl isomerase 1 (Pin1) preserves the phosphorylation state of tissue factor and prolongs its release within microvesicles-Reference-Cited by-同舟云学术

Peptidyl-prolyl isomerase 1 (Pin1) preserves the phosphorylation state of tissue factor and prolongs its release within microvesicles

Published:2018-01 Issue:1 Volume:1865 Page:12-24
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Ettelaie Camille,Collier Mary E.W.,Featherby Sophie,Greenman John,Maraveyas Anthony

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference57 articles.

1. Tissue factor non-coagulant signaling - molecular mechanisms and biological consequences with a focus on cell migration and apoptosis;Åberg;J. Thromb. Haemost.,2013

2. The many faces of tissue factor;Mackman;J. Thromb. Haemost.,2009

3. Posttranslational modifications of tissue factor;Butenas;Front. Biosci. (Elite Ed.),2012

4. Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor;Collier;J. Biol. Chem.,2011

5. p38α phosphorylates serine 258 within the cytoplasmic domain of tissue factor and prevents its incorporation into cell-derived microparticles;Ettelaie;Biochim. Biophys. Acta,1833

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation;Cells;2024-04-23

2. Regulation of tissue factor activity by interaction with the first PDZ domain of MAGI1;Thrombosis Journal;2024-01-17

3. Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications;British Journal of Cancer;2022-09-12

4. De-Palmitoylation of Tissue Factor Regulates Its Activity, Phosphorylation and Cellular Functions;Cancers;2021-07-30

5. Label-free proteomic analysis of serum exosomes from paroxysmal atrial fibrillation patients;Clinical Proteomics;2021-01-06